drugset / Trial / NCT02819921
Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen
Phase 4
Terminated
59 enrolled
Seoul National University Hospital
Korea Cancer Center Hospital · collabPfizer · collabSeoul National University Bundang Hospital · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a randomized, placebo-controlled study of desvenlafaxine versus placebo. The purpose of this study is to determine if desvenlafaxine was effective in decreasing the frequency and severity of hot flashes in breast cancer patients taking tamoxifen.
Timeline
- Start
- 2017-11-10
- Primary completion
- 2019-03-15
- Completion
- 2019-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desvenlafaxine | Other / unclassified | 50 mg | Oral |
| Subject | Desvenlafaxine | Other / unclassified | 100 mg | Oral |